Irritable Bowel Syndrome Clinical Trial
Official title:
Evaluation of the Ileocecal Valve in Patients With and Without Irritable Bowel Syndrome.(IBS)
The aim of the current study is to test the hypothesis that patients with IBS may have a
defective ICV pressures and may have small bowel bacterial overgrowth. The goal of the
current study is to identify the role and competence of ileocecal valve (ICV) in patients
with irritable bowel syndrome.
The primary objective is to measure the pressure of the ileocecal valve in patients with and
without irritable bowel syndrome (IBS). The Ileocecal valve reflux pressures during air
insufflation of cecum will be used.
This is an outpatient study. There will be no requirement to stay overnight in the hospital.
The research will be conducted in the gastroenterology section of the department of Medicine
in North shore university hospital and in North shore long island Jewish medical center. Both
these hospitals are tertiary care centers with adequate facilities for the safe and
appropriate conduct of this research. Participants must meet all eligibility criteria and
sign the consent form before enrolling in the study. This is a cohort study with 2 groups
(patients with IBS and participants without IBS). Patients will be enrolled into one of these
two categories based on their medical history, signs and symptoms and questionnaire. There
are no controlled compounds used in this study. There is no treatment involved in this study.
There are 2 study related visits per subject.
Based on questionnaire we plan to recruit 25 participants who meet the criteria of IBS and 25
participants who do not meet the criteria of IBS (Total of 50 participants in the study).
Patients with IBS are those who meet the criteria of IBS based on their symptoms and the
responses to a validated ROME III - questionnaire. All other participants who do not meet the
criteria for IBS are classified as non-IBS participants. All the participants should be
having a clinically indicated colonoscopy.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03720314 -
Microbiota Profiling in IBS
|
||
| Recruiting |
NCT06166563 -
Exercise, Irritable Bowel Syndrome and Fibromyalgia
|
N/A | |
| Completed |
NCT05213910 -
Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains
|
N/A | |
| Recruiting |
NCT05985018 -
Traditional Dietary Advice Vs. Mediterranean Diet in IBS
|
N/A | |
| Completed |
NCT04486469 -
Efficacy of Physiotherapy Techniques on Irritable Bowel Syndrome (IBS). Pilot Study.
|
N/A | |
| Completed |
NCT06407609 -
Positive Outcomes of the Supplementation With Lecithin-based Delivery Form of Curcuma Longa and of Boswellia Serrata in IBS
|
N/A | |
| Completed |
NCT04656730 -
Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
|
Phase 4 | |
| Completed |
NCT04145856 -
Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico
|
Phase 4 | |
| Recruiting |
NCT04138225 -
The Ecological Role of Yeasts in the Human Gut
|
||
| Active, not recruiting |
NCT03586622 -
One Year Home Monitoring and Treatment of IBS Patients
|
N/A | |
| Completed |
NCT05207618 -
Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant
|
N/A | |
| Not yet recruiting |
NCT06369753 -
Visible Abdominal Distension
|
N/A | |
| Not yet recruiting |
NCT05157867 -
In Vivo Effects of Amylase Trypsin Inhibitors
|
N/A | |
| Not yet recruiting |
NCT05100719 -
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
|
N/A | |
| Recruiting |
NCT05001997 -
Effects of Lactose-free Dairy Products on Athletes With Irritable Bowel Syndrome
|
N/A | |
| Recruiting |
NCT02953171 -
Probiotics in the Treatment of Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT03266068 -
Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
|
||
| Completed |
NCT02977975 -
Lacto-fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT03318614 -
Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster
|
Phase 2/Phase 3 | |
| Completed |
NCT02980406 -
The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level
|
N/A |